Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies
CAMBRIDGE, England—-Pfizer Regenerative Medicine today announced that it has entered into a collaboration and license agreement with University College London focused on gaining better understanding into how to develop stem cell-based therapies for certain ophthalmic conditions.
[Read the full article here]Related News:
Pfizer, University College London enter pact to develop stem cell-based therapies
Einstein College receives grant to develop stem cell-based therapies
Pfizer Regenerative Medicine to work wth Athersys on stem cell therapies